Browse the evidence

Skeletal muscle hypertrophy from resistance training is driven primarily by chronic increases in translational capacity (ribosome biogenesis) and resting protein synthesis, rather than solely by acute post-exercise spikes in protein synthesis.

Focus on consistent resistance training over time to build more ribosomes in your muscles, which increases your baseline protein synthesis. Don't obsess over the exact timing of nutrients immediately post-workout, as total daily protein and long-term training consistency drive hypertrophy more than acute spikes.

Lean body mass is preserved on average in both TRF and MBD groups, but individual responses vary significantly, with some participants losing lean mass despite adequate protein intake.

While your group average lean mass stays stable, individual results vary. Ensure you are lifting weights and eating enough protein (1.4-2.0g/kg body weight or 2.3-3.1g/kg lean mass) to maximize the chance of preserving muscle while losing fat.

Polyphenols and unsaturated fats in the Mediterranean diet mitigate metabolic syndrome risk by suppressing proinflammatory cytokines and lipid peroxidation.

Use extra virgin olive oil as your primary fat source. It contains polyphenols that reduce inflammation and improve metabolic health, countering the negative effects of saturated and trans fats found in Western diets.

SGLT-2 inhibitors and DPP-4 inhibitors produce modest or neutral weight loss effects, respectively, making them less effective for weight management compared to GLP-1 agonists.

SGLT-2 inhibitors offer modest weight loss (3-5%), while DPP-4 inhibitors are generally weight-neutral or have mild effects. They are less effective for weight management than GLP-1 agonists. SGLT-2 inhibitors work by excreting glucose in urine, but compensatory mechanisms limit weight loss. DPP-4 inhibitors are better suited for glycemic control without significant weight impact.

In individuals with type 2 diabetes, a history of cardiovascular disease and higher baseline BMI are associated with modestly poorer cognitive function following an intensive lifestyle intervention compared to standard care.

For individuals with type 2 diabetes who are obese or have a history of cardiovascular disease, intensive lifestyle interventions may not improve cognitive function and could be associated with modestly poorer outcomes compared to standard care. These individuals should discuss potential risks and benefits with their healthcare provider.

Bariatric surgery improves periconception maternal health by normalizing hormonal axes and restoring menstrual cycle regularity, which leads to increased fertility, without increasing the risk of miscarriages or congenital malformations.

If you are considering bariatric surgery and plan to conceive, expect that your fertility will likely improve and menstrual cycles will become regular. However, you must commit to lifelong vitamin supplementation and regular monitoring to prevent deficiencies. Postpone pregnancy until weight loss stabilizes and vitamin levels are normalized to ensure optimal health for you and the fetus.

Behavioral weight management interventions (WLs and WLMs) generally do not exacerbate health inequalities, as most trials find no significant gradient in uptake, adherence, or outcomes across socioeconomic and demographic groups.

Most behavioral weight loss programs work similarly across different social groups. If you are from a disadvantaged background, do not assume the program will fail you; most evidence shows no difference in outcome compared to advantaged groups. However, if you do struggle with adherence, it may be because the program requires high personal agency (time/education) which might be a barrier for you.

Weight loss outcomes (kg or % loss) in behavioral interventions do not consistently favor either 'more' or 'less' advantaged groups, with most trials finding no significant difference in weight loss by socioeconomic or demographic status.

Your socioeconomic background does not predict your weight loss success. While you might face more barriers to starting or sticking with a program, if you do complete it, you are likely to lose the same amount of weight as anyone else.

Saturated long-chain fatty acids (LCFAs) promote insulin resistance and ectopic fat deposition via diacylglycerol (DAG) and ceramide accumulation, whereas medium-chain fatty acids (MCFAs) and polyunsaturated fats do not produce these detrimental effects.

Limit saturated long-chain fatty acids (found in animal fats and dairy) and prioritize unsaturated fats (olive oil, nuts, fish) and medium-chain fats. The source of fat significantly impacts metabolic health.

Dietary fiber intake improves metabolic health by increasing short-chain fatty acid (SCFA) production, which activates G-protein-coupled receptors (GPCRs) to enhance insulin sensitivity, energy expenditure, and gut microbiome diversity.

Aim for 25-38g of fiber daily from whole plant sources. This supports gut health and metabolic function via SCFA production.

Ketogenic diets (less than 50g carbohydrate/day) induce nutritional ketosis, shifting the body's primary fuel source from glucose to ketones and fatty acids, which may provide unique therapeutic benefits beyond weight loss.

If you want to enter ketosis, restrict carbohydrates to under 50 grams per day while maintaining moderate protein intake. Expect your body to switch to burning fat and ketones for fuel. Monitor your electrolytes to avoid initial side effects.

Supplementation with omega-3 fatty acids significantly reduces triglycerides in individuals with familial hypercholesterolemia, but has no significant impact on total or LDL cholesterol.

For FH patients, high-dose omega-3s (4-6g/day) are effective at lowering triglycerides. However, do not expect them to significantly lower LDL cholesterol. They are best used as an adjunct for triglyceride management, not as a primary cholesterol-lowering strategy.

In Korean adults, an energy intake distribution of 50–60% carbohydrates, 30–40% fat, and 20–30% protein is associated with the lowest all-cause mortality risk.

For Korean adults, aiming for 50-60% of calories from carbohydrates, 30-40% from fat, and 20-30% from protein is associated with the longest life expectancy. This suggests revising current dietary guidelines to lower the recommended carbohydrate range and potentially increase healthy fat intake within this optimal window.

Caloric restriction (CR) and exercise extend lifespan and delay age-related diseases by targeting mitochondrial function, specifically through enhanced ATP production, improved Ca2+ homeostasis, and activation of AMPK/SIRT1 pathways.

To leverage mitochondrial health for longevity, prioritize regular physical activity and consider moderate caloric restriction. Exercise directly improves mitochondrial biogenesis and Ca2+ handling, while CR enhances energy production and antioxidant defenses. Focus on nutrient density to maintain health while reducing overall intake.

Binge Eating Disorder (BED) in patients with Type 2 Diabetes (T2DM) is associated with poorer glycemic control, specifically higher HbA1c levels and increased insulin resistance, independent of BMI in some contexts.

If you have T2DM and struggle with binge eating, addressing the binge episodes is crucial for your blood sugar control. The paper indicates that frequent binges are linked to higher HbA1c and insulin resistance, even when accounting for weight. You should discuss these behaviors with your healthcare provider openly, as they are a known medical risk factor, not a personal failing, and treating BED can improve your diabetes outcomes.

Intensive glucose-lowering strategies in type 2 diabetes significantly reduce the risk of non-fatal myocardial infarction and microvascular complications (retinopathy, nephropathy) compared to standard therapy, but do not significantly reduce major adverse cardiovascular events (MACE) or all-cause mortality.

For people with Type 2 Diabetes, aiming for very low blood sugar levels (intensive control) is beneficial for protecting your eyes and kidneys, and may slightly reduce the risk of non-fatal heart attacks. However, it does not significantly reduce the risk of major heart events, stroke, or death compared to standard control. Therefore, intensive glucose lowering should be combined with aggressive management of blood pressure and lipids, rather than being the sole focus for heart health.

Mandatory labeling of added sugars on packaged foods and beverages leads to reduced consumption, resulting in significant prevention of cardiovascular disease and type 2 diabetes cases, along with net healthcare cost savings.

Support the timely implementation of FDA added sugar labeling on packaged foods. This policy leverages consumer choice to reduce sugar intake, which directly lowers the risk of heart disease and diabetes while saving billions in healthcare costs. The benefits are maximized when the label also encourages manufacturers to reformulate products to contain less sugar.

Resistance training-induced muscle hypertrophy is regulated by a core set of 141 genes, including specific regulation of mRNA 3' and 5' untranslated regions (UTRs), which directly modulate protein synthesis and lean mass gains.

To maximize muscle growth, focus on consistent resistance training. The research suggests that individual genetic responses (specifically how your body regulates gene expression via UTRs) dictate your growth potential. While you cannot change your genes, understanding that 'responders' and 'non-responders' exist at a molecular level may help manage expectations. Consistency is key, as the molecular machinery adapts to the loading stimulus.

Higher baseline levels of food addiction, as measured by the Yale Food Addiction Scale, are associated with increased odds of both trial attrition and 12-month weight gain in behavioral weight-loss interventions.

If you struggle with intense cravings or loss of control over certain foods, standard willpower-based dieting may fail. Consider interventions that reduce exposure to triggering foods, such as meal replacements or highly structured meal plans, to bypass the need for constant decision-making.

Higher baseline self-efficacy for nutrition change and higher outcome expectations are associated with increased odds of trial attrition, suggesting that overconfidence may lead to disappointment and dropout when weight loss is slower than expected.

If you are highly confident in your ability to lose weight, be aware that unrealistic expectations can lead to dropout if progress is slow. Focus on building sustainable habits rather than rapid results to maintain long-term engagement.

Identifying as non-Hispanic white, being married or living with a partner, and having higher family encouragement are associated with lower odds of 12-month weight gain among trial completers.

If you lack strong social support at home, actively seek external accountability through group programs, friends, or coaches to replicate the support structure provided by marriage or family.

Implementing a 20% tax on sugar-sweetened beverages (SSBs) significantly reduces SSB intake, with the magnitude of reduction being highest in low-income countries and among young adults.

For policymakers, a 20% tax on sugary drinks is a highly effective tool, especially in lower-income countries where it can reduce consumption by 15-24%. In wealthier nations, the effect is smaller (around 7-8%) and may require larger taxes or combined interventions like education campaigns to be effective for older demographics.

GLP-1 receptor agonists (GLP-1RAs) significantly improve liver enzymes (AST, ALT, GGT) and reduce fibrosis scores in patients with MAFLD and T2DM, though they are not recommended as a primary treatment for NASH histology in the absence of diabetes.

If you have type 2 diabetes and fatty liver, GLP-1 medications (like Semaglutide) can significantly improve your liver enzymes and reduce scarring markers. They are recommended by guidelines for this specific group. However, they can cause stomach issues like nausea, which leads many people to stop taking them. Discuss with your doctor if the benefits for your liver and heart outweigh the side effects.

Obesity (BMI > 30) in early-stage chronic kidney disease (CKD) causes or worsens CKD through obesity-associated nephropathy (OAN), characterized by glomerular hypertrophy, hyperfiltration, albuminuria, and focal segmental glomerulosclerosis (FSGS).

If you have a BMI over 30 and are in early stages of kidney disease, your weight is likely actively damaging your kidneys through inflammation and high blood pressure in the kidney filters. You should prioritize weight loss through lifestyle changes or medical supervision to prevent progression to advanced stages.